Skip to main content

View full-text article in PMC

. 2023 Jan 20;54(1):186–191. [Article in Chinese] doi: 10.12182/20230160111

表 3. Comparison of serum indicator levels of Hp-positive and Hp-negative subjects in each group.

各组Hp阳性、阴性者血清指标水平对比

Group	Hp	n	PGⅠ/(μg/L)	PGⅡ/(μg/L)	PGⅠ/PGⅡ	CEA/(ng/mL)	CA199/(U/mL)	CA724/(U/mL)
^a P<0.05, vs. Hp-positve subjects.
Healthy	+	26	148.57±23.56	14.59±2.36	10.18±2.02	3.85±0.54	13.06±2.15	3.98±0.63
	－	78	131.33±20.49^a	11.22±2.19^a	11.70±2.13^a	2.57±0.42^a	10.97±1.92^a	2.90±0.44^a
Benign	+	90	120.61±21.03	15.36±2.11	7.85±1.41	3.48±0.61	13.57±2.24	3.85±0.52
	－	25	96.78±16.35^a	6.76±1.29^a	14.32±2.03^a	1.46±0.28^a	6.62±1.16^a	1.41±0.26^a
Low grade	+	86	110.65±18.36	16.97±2.25	6.52±1.33	7.44±1.42	25.56±5.45	7.88±1.36
	－	26	79.38±14.26^a	7.79±1.32^a	10.19±1.65^a	4.34±0.83^a	17.03±3.32^a	4.91±0.88^a
High grade	+	83	99.52±16.73	18.22±2.46	5.46±1.21	9.26±1.69	29.35±6.04	9.51±1.57
	－	26	65.81±12.18^a	8.75±1.37^a	7.52±1.28^a	5.86±1.17^a	23.15±4.71^a	6.74±1.26^a
Gastric cancer	+	81	61.39±10.48	30.95±5.63	1.98±0.36	86.79±15.64	148.62±23.56	77.25±14.39
	－	28	47.65±6.27^a	17.60±3.39^a	2.71±0.48^a	23.73±4.16^a	72.79±14.08^a	34.85±5.46^a